Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

Clinical trial NCT07293260 · RECRUITING

Trial details

NCT number: NCT07293260
Sponsor: Amgen
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiovascular Disease

Start date: 2026-03-23
Primary completion: 2028-06-15
Enrollment: 406

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.